Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (481-490 of 562) with videos related to

Pageof 57
Sort By:
Brain Pathology (Zurich, Switzerland)|February 19, 2017
Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelinationAlonso Barrantes-Freer, Aylin Sophie Engel, Odir Antonio Rodríguez-Villagra, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.
Acta Neuropathologica|September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaDaniel Picard, Jörg Felsberg, Maike Langini, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Cell|March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial DiagnosisVerena Körber, Jing Yang, Pankaj Barah, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Pageof 57

Showing results (481-490 of 562) with videos related to

Sort By:
Pageof 57
Brain Pathology (Zurich, Switzerland)|February 19, 2017
Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelinationAlonso Barrantes-Freer, Aylin Sophie Engel, Odir Antonio Rodríguez-Villagra, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Neuro-Oncology|February 18, 2020
Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytomaAntje Wick, Tobias Kessler, Michael Platten, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
Acta Neuropathologica|May 8, 2019
RhoA regulates translation of the Nogo-A decoy SPARC in white matter-invading glioblastomasPeter Wirthschaft, Julia Bode, Himanshu Soni, et al.
Acta Neuropathologica|September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaDaniel Picard, Jörg Felsberg, Maike Langini, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Cell|March 26, 2019
Evolutionary Trajectories of IDH<sup>WT</sup> Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial DiagnosisVerena Körber, Jing Yang, Pankaj Barah, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
Pageof 57